Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 109.74 -2.27 (-2.03%) Market Cap: 6.92 Bil Enterprise Value: 11.03 Bil PE Ratio: 22.63 PB Ratio: 1.87 GF Score: 78/100

Jazz Pharmaceuticals PLC at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2020 / 03:20PM GMT
Release Date Price: $112.56 (-0.43%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

Okay. Good morning, everyone. Welcome to the 11:20 session here at the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover European biopharma as well as U.S. biopharma for the firm, and I'm delighted to be hosting in a fireside chat with you today, Jazz Pharmaceuticals. With us today, we have Bruce Cozadd, who is CEO and Co-founder of the company; and Rob Iannone, who heads up R&D. So thank you both for joining us. Maybe just to kick things off from a very high level, maybe we'll start with you, Bruce. You were a Co-founder of the company. This goes back several years now. And obviously, you've been CEO for over 10 years now. And so first, let me congratulate you on the successes that you've had with Jazz.

Questions & Answers

Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

And maybe we could start off, just at a very high

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot